Bing

SEARCH HISTORY

According to a Schedule 13G filing, the fund upped its bet by 23.6%, and now owns 5.17 million shares of Common Stock, which account for 17.52% of the Aegerion Pharmaceuticals, Inc. (NASDAQ:AEGR)’s shares outstanding. Also today, Hal Mintz’s …
INSIDER MONKEY · 10/15/2014
What: Shares of Aegerion Pharmaceuticals (NASDAQ: AEGR ) , a biopharmaceutical company focused on ... I'd suggest holding off on this stock for at least another quarter. If you think Juxtapid's growth prospects are intriguing, then this revolutionary ...
The Motley Fool · BySean Williams · 11/6/2014
AEGR), a biopharmaceutical company dedicated to the development and commercialization of innovative therapies for patients with debilitating rare diseases, today announced that on July 1, 2015, Aegerion granted stock options to purchase an aggregate of ...
GlobeNewswire · 7/13/2015
Aegerion Pharmaceuticals (NASDAQ:AEGR) is a classic example of a much hyped biotech failing to deliver on its promise. In 2013, the company promised a great deal as its lead product candidate was approved by the FDA. That year saw the stock gain …
Seeking Alpha · 5/6/2015
Aegerion Pharmaceuticals, Inc. operates as a biopharmaceutical company.It is engaged ... 07/14 AEGERION PHARMACEUTICALS: Grants Stock Options Under Inducement Program 07/14 AEGERION PHARMACEUTICALS: Grants Stock Options Under …
4 Traders · 7/24/2015
Free in-depth research on AEGR is available at: Equity Research Institute ("ERI") produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and …
Market Watch · 7/17/2015
Aegerion Pharmaceuticals, Inc. (AEGR) posted disappointing earnings in after-hours Thursday, leading many analysts to downgrade the stock the following morning. Investment banks such as JPMorgan Chase & Co. (JPM), Bank of America Corp (BAC) …
bidnessetc.com · 11/3/2014
Some of the biggest gainers among healthcare stocks include: Isis Pharmaceuticals (ISIS): ISIS stock is up 7.1% ... http://investorplace.com/2014/06/biggest-movers-in-healthcare-stocks-now-isis-sgen-aria-clvs-isis-sgen-aria/.
Investor Place · 6/10/2014